Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.50 |
| ▸ | LAP3 | P28838 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.31 |
| ▸ | FDPS | P14324 | 2/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27823317 | 0.87 | SMPD1 (0.56) | SMPD1LAP3MMP1MMP2CA12 | |
| SCHEMBL2523085 | 0.86 | SMPD1 (0.36) | SMPD1LAP3MMP1MMP2CA12 | |
| SCHEMBL2523115 | 0.80 | TSHR (0.33) | SMPD1 | |
| SCHEMBL2048208 | 0.79 | SMPD1 (0.48) | SMPD1LAP3MMP1MMP2CA12 | |
| SCHEMBL28389879 | 0.79 | SMPD1 (0.44) | SMPD1LAP3FDPS | |
| SCHEMBL26662204 | 0.79 | SMPD1 (0.44) | SMPD1LPAR3LPAR1LPAR2ENPP2 | |
| SCHEMBL2048023 | 0.76 | SMPD1 (0.50) | SMPD1LAP3PTPN1LPAR3LPAR1 | |
| SCHEMBL10324049 | 0.76 | SMPD1 (0.46) | SMPD1LAP3PTPN1 | |
| SCHEMBL27538749 | 0.76 | SMPD1 (0.46) | SMPD1LAP3PTPN1 | |
| SCHEMBL28702629 | 0.74 | SMPD1 (0.44) | SMPD1LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| JP-11043493-A | — | — | None | — | — | JP | disclosed |
| EP-2337805-B2 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | MITSUI CHEMICALS INC (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-119654413-A | ITFG1 inhibitory nucleic acids | 莱尔纳生物制药私人有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2025031485-A1 | DSRNA MOLECULE INHIBITING HBV GENE EXPRESSION AND USE THEREOF | 石药集团中奇制药技术（石家庄）有限公司 | 2025-02-13 | — | — | WO | disclosed |
| EP-3129353-B1 | METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2024-02-28 | — | — | EP | disclosed |
| CN-116802294-A | Therapeutic agent for treating neurodegenerative disease | UCL商业有限公司 | 2023-09-22 | — | — | CN | disclosed |
| WO-2023106258-A1 | POLYMERIZABLE COMPOSITION FOR MANUFACTURING MOLDED ARTICLE, MOLDED ARTICLE AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS, INC. (JP) | 2023-06-15 | — | — | WO | disclosed |
| CN-110183603-B | Phosphorus-containing release agent, optical polymerizable composition containing same, and method for producing same | SKC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| US-20170029552-A1 | COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES | COVESTRO DEUTSCHLAND AG (DE) | 2017-02-02 | — | — | US | disclosed |
| EP-2337805-B1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2014-12-17 | — | — | EP | disclosed |
| US-8829147-B2 | Polymerizable liquid composition and process for the production of organic glass starting from polymerizable liquid compositions of the polyurethane type | ACOMON AG (CH) | 2014-09-09 | — | — | US | disclosed |
| EP-2571914-A1 | A POLYMERIZATION CATALYST FOR POLYTHIOURETHANES, POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC POLYTHIOURETHANE GLASS WITH A HIGH REFRACTIVE INDEX | Mitsui Chemicals, Inc. (JP) | 2013-03-27 | — | — | EP | disclosed |
| WO-2011144995-A1 | A POLYMERIZATION CATALYST FOR POLYTHIOURETHANES, POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC POLYTHIOURETHANE GLASS WITH A HIGH REFRACTIVE INDEX | ACOMON AG (CH) | 2011-11-24 | — | — | WO | disclosed |
| US-20110251301-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-10-13 | — | — | US | disclosed |
| EP-2337805-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010043392-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2010-04-22 | — | — | WO | disclosed |
| JP-H1143493-A | NEW PHOSPHORIC ESTER AND MOLD RELEASE AGENT COMPOSED OF THE SAME COMPOUND | MITSUI CHEM INC | 1999-02-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | SMPD1 3130/4885LAP3 2067/4885MMP1 2866/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | SMPD1 3130/4885LAP3 2067/4885MMP1 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.